DUBLIN--(BUSINESS WIRE)--The "Cardiac Surgery Device Market | EU | Units Sold, Average Selling Prices, Market Values, Shares, Product Pipeline, Forecasts, SWOT | 2018-2024 | MedSuite" report has been added to ResearchAndMarkets.com's offering.
The rising adoption of minimally invasive heart valve therapies, such as TMVR and TAVI, has driven substantial growth in the total European cardiac surgery market.
As of 2017, TAVI remained the largest revenue generator among transcatheter heart valve therapies. Growth in this market will be driven by the large potential patient population, improved diagnostic capabilities, new product launches, positive clinical results and favorable reimbursement conditions. The transcatheter mitral valve repair market, though smaller than TAVI, is also expected to grow rapidly over the forecast period, benefitting from many of the same drivers as TAVI.
Companies Mentioned
- Medtronic
- Abbott
- Edwards Life Sciences
- LivaNova
- Maquet
- Abiomed
- W.L. Gore
Key Topics Covered:
1. Research Methodology
2. Disease Overview
3. Product Assessment
4. European Cardiac Surgery Device Market Overview
5. Country Profiles
6. Procedure Numbers
7. Tissue Heart Valve Market
8. Mechanical Heart Valve Market
9. Annuloplasty Repair Device Market
10. Transcatheter Mitral Valve Repair Device Market
11. Transcatheter Aortic Valve Implantation Market
12. On-Pump Coronary Artery Bypass Device Market
13. Off-Pump Coronary Artery Bypass Device Market
14. Endoscopic Vessel Harvesting Device Market
15. Anastomosis Assist Device Market
16. Ventricular Assist Device Market
17. Intra-Aortic Balloon Pump Device Market
18. Artificial Heart Device Market
19. Patent Foramen Ovale Closure Device Market
20. Atrial And Ventricular Septal Defect Closure Device Market
For more information about this report visit https://www.researchandmarkets.com/research/rwblhv/eu_cardiac?w=4
